High quality Orlistat Orlistat Healthy Weight Loss

Legal Weight Loss Pharma Chemical Orlistat Diet Fat Lose Antiobesity CAS 96829-58-2

CAS 96829-58-2 Orlistat
Product name: Orlistat, Myalli
CAS: 96829-58-2
MF: C29H53NO5
MW: 495.73
Usage :pharmaceutical raw materials, the hormone
Assay: 99%
Appearance:White Crystalline Powder

Orlistat is a drug that promotes loss of weight by preventing the digestion and absorption of fat in food. In the intestine, an enzyme called lipase (produced primarily by the pancreas) breaks apart fat in food so that it can be absorbed into the body. Orlistat blocks the action of lipase and thereby prevents the breakup and absorption of fat. Orlistat blocks absorption of about 25% of the fat in a meal. The unabsorbed fat is excreted in the stool.
orlistat adverse effects
This medication is used along with a doctor-approved reduced-calorie diet, exercise, and behavior modification program to help significantly overweight (obese) persons lose weight. Taking orlistat can also help prevent you from regaining the weight you have lost. Losing weight and keeping it off can reduce the many health risks that obesity causes, including heart disease, diabetes, high blood pressure, some forms of cancer, certain breathing problems, and a shorter life span.

Dietary fats need to be broken down into smaller pieces before the body can absorb them. Orlistat works by blocking the enzyme that breaks down fats in your diet. This undigested fat then passes out of your body in your bowel movement. Orlistat does not block the absorption of calories from sugar and other non-fat foods, so you still need to restrict your total intake of calories.
orlistat mechanism of action
Application

Orlistat is used for the treatment of obesity. The amount of weight loss achieved with orlistat varies. In one-year clinical trials, between 35.5% and 54.8% of subjects achieved a 5% or greater decrease in body mass, although not all of this mass was necessarily fat. Between 16.4% and 24.8% achieved at least a 10% decrease in body fat.After orlistat was stopped, a significant number of subjects regained weight-up to 35% of the weight they had lost.

The incidence of type 2 diabetes in an obese population over four years is decreased with orlistat (6.2%) compared to placebo (9.0%).Long-term use of orlistat also leads to a modest reduction in blood pressure (mean reductions of 2.5 and 1.9 mmHg in systolic and diastolic blood pressure respectively).

Contact us if you need more details on Orlistat Mechanism of Action. We are ready to answer your questions on packaging, logistics, certification or any other aspects about Orlistat Adverse Effects、Orlistat 120mg Capsules. If these products fail to match your need, please contact us and we would like to provide relevant information.

Product Categories : Hot sellers API